Inexpensive Oral Rinse Test May Distinguish Head And Neck Cancer Patients From People Who Are At High Risk For The Disease

Medscape (6/7, Harrison) reports that “an inexpensive oral rinse test has been shown to distinguish head and neck cancer patients from people who are at high risk for the disease, and offers hope that the diagnosis of oral cancer could be made at a much earlier stage than it is currently.” According to Medscape, “the test, OraMark, measures levels of a specific biomarker and total protein in a sample of saliva and has just become commercially available.”